HIGHLIGHTS
- who: NF and colleagues from the Division of Molecular Oncology, Aichi Cancer Center Research Institute, Kanokoden, Chikusa-ku, Department of Cancer Genetics, Nagoya University Graduate School of Medicine, Nagoya, Japan have published the paper: Targeting the Is New Potential Therapeutic Modality for Malignant Mesothelioma, in the Journal: (JOURNAL)
- what: The results of this study demonstrated that inhibiting EZH2 suppressed the proliferation of BAP1-mutant MM cell lines, suggesting that EZH2 inhibitors may represent promising candidate therapeutic agents for MM .
- future: Merlin inactivation may also be caused via the upregulated expression of potential NF2 . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.